The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities

Short Title:
EMA/CHMP/ CVMP/ SWP/169430/2012

European Commission, Enterprise and Industry;

Document Type:
When different medicinal products are produced in shared facilities, the potential for cross-contamination is a concern. Medicinal products provide a benefit to the intended patient or target animal; however as a cross contaminant, they provide no benefit to the patient or target animal and may even pose a risk.

Go back

GMP Conferences by Topics